Skip to content
Nanoform logo — Nanoform uses platform technologies to develop innovative na...

Nanoform

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance.

Founded 2015 Finland Finland Grant Total: $46.30M Biotechnology, Pharmaceutical

General Information

Company Name Nanoform
Founded Year 2015
Location Finland Finland
Founders / Decision Makers
Team member
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Nanoform. To contact Nanoform, visit nanoform.fi.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nanoform compare?

A PDF of Nanoform and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nanoform soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nanoform

Nanoform is a pioneering enterprise founded in 2015, specializing in manufacturing nanoparticle-based medicines with the aim of revolutionizing the drug development industry. The company's slogan "Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance" encapsulates its core mission. Nanoform collaborates with pharmaceutical and biotechnology partners worldwide to develop cutting-edge medications and offer new possibilities for patients. The company's advanced platform technologies are utilized to optimize drug molecules' effectiveness and diminish clinical attrition rates. Its services include GMP manufacturing, formulation assistance, and solutions for drug solubility, bioavailability, and innovative drug delivery systems. Nanoform's last investment of €4.30M, a grant investment at 15 February 2024, was secured from Business Finland. Operating from Finland, Nanoform is poised to make significant contributions to the biotechnology and pharmaceutical industries.

Business keywords: nanoparticle medicines, drug development, pharmaceutical, nanotechnology, drug delivery systems, GMP manufacturing, formulation assistance, bioavailability, clinical development, drug solubility, platform technologies, innovation, clinical attrition

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €4.30M 1
Business Finland
15 Feb 2024
Post IPO Equity €25.00M -
22 Mar 2022
Venture Round €10.00M 2
Ilmarinen, Mandatum Life Insurance Company
02 Jul 2019
Corporate Round €7.00M -
21 Sep 2018

Nanoform Alternatives & Competitors

View All Alternatives
Nanoform vs

Phase-transition technology platform for enhancing solubility of BCS 2 & 4 APIs without the use of e...

Seed
4 employees
Biotechnology, Pharmaceutical
Nanoform vs

NanoCarrier's core technology, "micellar nanoparticles technology", was proposed and has been resear...

Post-IPO Debt
14 employees
Biotechnology, Pharmaceutical
Nanoform vs

Your Integrated CDMO Specialist. Driven by experts, led by science.

Private Equity
123 employees
Biotechnology, Industrial

FAQ About Nanoform

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance.
Nanoform was founded in 2015.
Nanoform is headquartered in Finland.
Nanoform operates in Biotechnology and Pharmaceutical. Its work centres on nanoparticle medicines, drug development, pharmaceutical and nanotechnology.
Nanoform has completed 4 funding rounds, raising a total of $46.30M. The latest funding stage is Grant.
Top alternatives and competitors to Nanoform include NanoPharmaSolutions, Inc., NanoCarrier Ltd., Upperton Pharma Solutions, leon-nanodrugs, Finopotamus. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanoform and NanoPharmaSolutions, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nanoform, https://bouncewatch.com/company/nanoform, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout